The Hereditary Pancreatic Cancer Panel screens for mutations in 32 genes that are associated with increased risk of developing pancreatic cancer. This test is recommended for individuals with a family history of pancreatic, breast, or ovarian cancers, or those who have had pancreatic cancer at a young age. Understanding your genetic risk can influence surveillance strategies and inform family planning. The panel helps identify individuals who may benefit from more frequent screening, lifestyle changes, or preventive interventions. It’s also valuable in determining eligibility for clinical trials and targeted therapies in known carriers.